AU7865791A - Anti-actinic agent - Google Patents

Anti-actinic agent

Info

Publication number
AU7865791A
AU7865791A AU78657/91A AU7865791A AU7865791A AU 7865791 A AU7865791 A AU 7865791A AU 78657/91 A AU78657/91 A AU 78657/91A AU 7865791 A AU7865791 A AU 7865791A AU 7865791 A AU7865791 A AU 7865791A
Authority
AU
Australia
Prior art keywords
actinic
agent
actinic agent
nicotinamide
systemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU78657/91A
Other versions
AU645092B2 (en
Inventor
Gerhard Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7865791A publication Critical patent/AU7865791A/en
Application granted granted Critical
Publication of AU645092B2 publication Critical patent/AU645092B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal (AREA)
  • Prostheses (AREA)
  • Glass Compositions (AREA)

Abstract

The invention relates to the use of nicotinamide, folic acid and/or combinations thereof for systemic and/or topical prophylaxis of the damaging effect of light on skin and to a suitable anti-actinic agent.
AU78657/91A 1990-06-13 1991-05-24 Anti-actinic agent Ceased AU645092B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4018964A DE4018964C1 (en) 1990-06-13 1990-06-13
DE4018964 1990-06-13

Publications (2)

Publication Number Publication Date
AU7865791A true AU7865791A (en) 1992-01-07
AU645092B2 AU645092B2 (en) 1994-01-06

Family

ID=6408360

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78657/91A Ceased AU645092B2 (en) 1990-06-13 1991-05-24 Anti-actinic agent

Country Status (8)

Country Link
EP (1) EP0486632B1 (en)
JP (1) JPH0635387B2 (en)
AT (1) ATE108993T1 (en)
AU (1) AU645092B2 (en)
CA (1) CA2059641A1 (en)
DE (2) DE4018964C1 (en)
ES (1) ES2061248T3 (en)
WO (1) WO1991019478A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341001A1 (en) * 1993-12-02 1995-06-08 Beiersdorf Ag Topical preparations containing L-arginine
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions
DE10021468A1 (en) * 2000-05-04 2001-11-08 Basf Ag Use of PARP inhibitors in cosmetic preparations
DE10062401A1 (en) * 2000-12-14 2002-06-20 Beiersdorf Ag Use of folic acid and / or derivatives thereof for the preparation of cosmetic or dermatological preparations for the prophylaxis of damage to the skin's own DNA and / or to repair damage already occurred to the skin's own DNA
CH696628A5 (en) * 2002-02-26 2007-08-31 Eprova Ag Use of folate suitable for the manufacture of a preparation for the prevention and treatment of inflammation and inflammation-associated diseases, in particular for influencing the
US20040191278A1 (en) 2003-03-31 2004-09-30 Christensen Flemming Kjaergaar Topical agent for application to the skin prior to luminous treatment
ES2292280B2 (en) * 2004-12-01 2008-12-01 Antonio Navarro Perez SUPPORT ANCHOR SYSTEM FOR WORK PROTECTION NETWORKS.
FR2894142B1 (en) * 2005-12-05 2009-06-12 Oreal USE OF THE TYROSINE-ARGININE DIPEPTIDE AND NIACIMANIDE ASSOCIATION AS A P-SUBSTANCE ANAGONIST
US8858968B2 (en) 2005-12-05 2014-10-14 L'oreal Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
KR101275351B1 (en) * 2010-06-29 2013-06-17 (주)아모레퍼시픽 Cosmetic Composition for Preventing Skin Aging

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096712A1 (en) * 1970-06-29 1972-02-25 Giraux Georges Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
DE2242553A1 (en) * 1972-08-30 1974-03-07 Koehler Valentin Cosmetic compsns contg folic acid or its salts - exerting antiseborrhoic effect and suppressing skin ageing
JPS59173124A (en) * 1983-03-19 1984-10-01 Shiseido Co Ltd Emulsified composition
LU87145A1 (en) * 1988-02-26 1989-09-20 Oreal METHOD FOR IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN USING POLYVITAMIN MIXTURES

Also Published As

Publication number Publication date
CA2059641A1 (en) 1991-12-14
WO1991019478A1 (en) 1991-12-26
AU645092B2 (en) 1994-01-06
EP0486632B1 (en) 1994-07-27
JPH05500230A (en) 1993-01-21
EP0486632A1 (en) 1992-05-27
JPH0635387B2 (en) 1994-05-11
ATE108993T1 (en) 1994-08-15
ES2061248T3 (en) 1994-12-01
DE4018964C1 (en) 1991-07-04
DE59102350D1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
AU6985691A (en) Pharmaceutical and cosmetic compositions
AU697584B2 (en) Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
AU5296593A (en) Concentrated mouthrinse for efficient delivery of antimicrobials
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
GR3003569T3 (en)
AU8626191A (en) Pyrimidine derivative, production thereof, and androgen inhibitor
AU645092B2 (en) Anti-actinic agent
AU7270794A (en) Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
DE69431162D1 (en) Fenbendazolformulierungen
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU635870B2 (en) Hydrazone derivatives, processes for production thereof, and uses thereof
AU2302288A (en) 4-quinoline-3-carboxylic acid derivatives and their use as antibacterial agents
AU2861389A (en) Disubstituted pyridines
FI911207A0 (en) Process for the preparation of new therapeutically useful retinoid
PT910367E (en) USE OF VITAMIN E ACETATE
AU641279B2 (en) Oligosaccharide derivatives
ES2174113T3 (en) NEW DERIVATIVES OF ((3-ALCOXI-FENOXI) -ETIL) -DIALQUILAMINE AND ITS USE AS LOCAL ANESTHETICS.
AU508605B2 (en) 4, 5-Diaryl-2-Mercaptoimidazole derivatives and their use asanti-inflammatory and immunosuppressive agents
AU8844091A (en) Novel dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihidroquinoline derivatives as modulators of the arachidonic acid cascade
AU3959889A (en) Benzimidazole derivatives, and their production and use
AU3070192A (en) Uses of 1,1,1,3,3,3-hexafluoropropane
AU5589294A (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
DE3869156D1 (en) FUNGICIDE 2-ANILINTHIAZOLINE.
AU533275B2 (en) 2-amino or 2-thio derivatives of 4,5-diphenyl-oxazole
TR27776A (en) 2-oxymino-2-thienyl-acetic acid derivatives.